Immune-Related Uncommon Adverse Events in Patients with Cancer Treated with Immunotherapy

Immunotherapy has dramatically changed the therapeutic landscape of oncology, and has become standard of care in multiple cancer types in front or late lines of therapy, with some longstanding responses and outstanding results. Notwithstanding, its use has brought a totally unique spectrum of advers...

Descripción completa

Detalles Bibliográficos
Autores principales: Albarrán-Artahona, Víctor, Laguna, Juan-Carlos, Gorría, Teresa, Torres-Jiménez, Javier, Pascal, Mariona, Mezquita, Laura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9498261/
https://www.ncbi.nlm.nih.gov/pubmed/36140493
http://dx.doi.org/10.3390/diagnostics12092091

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9498261/
https://www.ncbi.nlm.nih.gov/pubmed/36140493
http://dx.doi.org/10.3390/diagnostics12092091

Ejemplares similares